NCT07151339 Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia
| NCT ID | NCT07151339 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Schleswig-Holstein |
| Condition | Preeclampsia |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2029-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-11-01 with a primary completion date of 2029-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)
Eligibility Criteria
Inclusion Criteria: * older than 18 yrs * diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy Exclusion Criteria: * unable for informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07151339 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Preeclampsia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07151339 currently recruiting?
Yes, NCT07151339 is actively recruiting participants. Contact the research team at Laura.Rakow@uksh.de for enrollment information.
Where is the NCT07151339 trial being conducted?
This trial is being conducted at Kiel, Germany.
Who is sponsoring the NCT07151339 clinical trial?
NCT07151339 is sponsored by University Hospital Schleswig-Holstein. The trial plans to enroll 100 participants.